BEGIN:VCALENDAR VERSION:2.0 METHOD:PUBLISH PRODID:-//ACC//Meetings//EN BEGIN:VTIMEZONE TZID:Eastern Standard Time BEGIN:STANDARD DTSTART:16011101T020000 RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:Eastern Standard Time END:STANDARD BEGIN:DAYLIGHT DTSTART:16010301T020000 RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:Eastern Daylight Time END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT DESCRIPTION:\n\n\nWebinar Overview\nJoin ACC's Academic Cardiology and Prev ention of Cardiovascular Disease Member Sections to explore the shift from traditional risk scores to direct disease detection using coronary artery calcium (CAC)\, biomarkers and precision imaging.\nAs cardiovascular prev ention evolves\, clinicians are increasingly caught between traditional pr obabilistic risk calculators and the emerging era of direct disease detect ion. This webinar\, a collaboration between ACC's Academic Cardiology and Prevention of Cardiovascular Disease Member Sections\, provides a comprehe nsive look at the evidence and application of modern risk stratification. The session begins with a deep dive into the academic and methodological f oundations of risk prediction and then will evaluate the statistical stren gths and limitations of traditional models while identifying the evidence- based "knowledge gaps" in the use of CAC\, apolipoprotein B (apoB) and lip oprotein(a) (Lp[a]).\nThe focus then shifts to clinical implementation\, e xploring how to translate these biomarkers and imaging tools into actionab le care. Participants will learn when to move beyond the standard lipid pa nel to identify hidden risks and how to utilize CAC scoring to reclassify risk\, guide treatment decisions and enhance shared decision-making with p atients. \nKey Objectives/Learning Outcomes:\n\nEvidence-Based Foundations : Critically assess the validity of traditional risk models vs. direct dis ease detection and the current state of evidence for newer biomarkers.\nPr ecision Lipid Management: Determine specific clinical scenarios that warra nt the use of apoB and Lp(a) to identify residual cardiovascular risk.\nIm aging-Guided Strategy: Understand the strategic use of CAC and atheroscler osis imaging to individualize prevention strategies and improve patient en gagement.\n\n\nWebinar Recording\n\n\n-->\n\nWebinar Participants\nModerat or - Simona Campa\, DNP\, ACNP-BC\nSpeaker - Nishant Shah\, MD\, FACC\nSpe aker - Vijay Nambi\, MD\, FACC\nSpeaker - Samuel Kim\, MD\, FACC\n\nCredit Information\nNo credit is being offered for this webinar.\n\n\n\n\n\n .videoWrapper {\n position: relative\;\n padding-bottom: 56.25%\; /* 16:9 */\n padding-top: 25px\;\n height: 0\;\n }\n .videoWrapp er iframe {\n position: absolute\;\n top: 0\;\n left: 0\;\n wi dth: 100%\;\n height: 100%\;\n }\n DTEND;TZID=Eastern Standard Time:20260617T131500 DTSTAMP:20260520T052203Z DTSTART;TZID=Eastern Standard Time:20260617T130000 LOCATION:Online - Eastern Time (ET) SEQUENCE:0 SUMMARY:Precision Prevention: Moving Beyond Traditional Risk Scores UID:ef299517-1bd4-4de7-9bf2-fef01dcd16cb@acc.org X-ALT-DESC;FMTTYPE=text/html:
\n
\n\n

Webinar Overvi ew

\n

Join ACC's Academic Cardiology and Prev ention of Cardiovascular Disease Member Sections to explore the shift from traditional risk scores to direct disease detection using coronary artery calcium (CAC)\, biomarkers and precision imaging.

\n

As cardiovascular prevention evolves\, clinicians are increasingly caught between traditional probabilistic risk calculators and the emerging era of direct disease detection. This webinar\, a collaboration between ACC's Ac ademic Cardiology and Prevention of Cardiovascular Disease Member Sections \, provides a comprehensive look at the evidence and application of modern risk stratification. The session begins with a deep dive into the academi c and methodological foundations of risk prediction and then will evaluate the statistical strengths and limitations of traditional models while ide ntifying the evidence-based "knowledge gaps" in the use of CAC\, apolipopr otein B (apoB) and lipoprotein(a) (Lp[a]).

\n

The focu s then shifts to clinical implementation\, exploring how to translate thes e biomarkers and imaging tools into actionable care. Participants will lea rn when to move beyond the standard lipid panel to identify hidden risks a nd how to utilize CAC scoring to reclassify risk\, guide treatment decisio ns and enhance shared decision-making with patients.

\n

Key Objectives/Learning Outcomes:

\n\n\n\n\n

Webinar Participan ts

\n

Moderator - Simona Campa\, DNP\, ACNP-BC
\nSpeaker - Nishant Shah\, MD\, FACC
\nSpea ker - Vijay Nambi\, MD\, FACC
\nSpeaker - Sa muel Kim\, MD\, FACC

\n\n

Credit Info rmation

\n

No credit is being offered for this webinar.< /em>

\n\n
\n\n
\n BEGIN:VALARM ACTION:Display DESCRIPTION:Reminder TRIGGER:-PT15M END:VALARM END:VEVENT END:VCALENDAR